Melbourne Clinical Trials
The Brain Wave Study
The study drug is exploring a potential new treatment for adult focal onset epilepsy.
2 sets of 7-night stays nights
5 visits
This study evaluates a potential new treatment for adult focal onset epilepsy, a type of epilepsy that causes seizures in specific areas of the brain. The drug works by blocking certain sodium channels that help control brain activity. Current treatments for focal epilepsy often cause side effects because they can’t target the problem areas without affecting normal brain function. This new medication aims to be more precise and better tolerated, meaning it should cause fewer side effects.
Call us on 1300 715 768 to discuss your eligibility today!
Eligibility
Biological Sex Female or Male
BMI 18 - 32kg/m²
Weight At least 50kg
Age 18-55 years old
Medical History No significant medical history
Medication Not taking any prescription medication
Smoking History Non-smokers and have not smoked for at least 3 months prior to dosing